Published in Cancer Weekly, November 17th, 2009
"with untreated colorectal adenocarcinoma were eligible in this study if they had measurable lesions. S-1 was administered on days 1-14, with doses starting from 60 mg/m(2) per day and escalating by 10 mg/m(2) at each dose level. Oxaliplatin was given at the fixed dose of 130 mg/m(2), through 2-h i.v. infusion on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.